GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
W

Wuhan Dazhong Dental Medical Co 2651.HK · HKD

N/A · HKEX · 🇭🇰 Hong Kong

Compare

21.36

-10.63%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥371.6m

FY2022FY2025

Net income

CN¥28.2m

FY2022FY2025

Free cash flow

CN¥80.1m

FY2022FY2025

Shareholders' equity

CN¥320.1m

FY2022FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022
RevenueCN¥371.6mCN¥407.1mCN¥441.8mCN¥409.4m
Gross profitCN¥191.9mCN¥209.0mCN¥229.2mCN¥211.8m
Research and developmentCN¥9.1mCN¥6.7mCN¥6.8mCN¥6.6m
Operating incomeCN¥65.9mCN¥70.8mCN¥83.2mCN¥65.3m
Net incomeCN¥28.2mCN¥38.3mCN¥46.5mCN¥37.1m
Diluted earnings per share0.480.780.780.63

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022
Total assetsCN¥515.0mCN¥378.0mCN¥491.0mCN¥459.5m
Cash and short-term investments—CN¥95.0mCN¥227.1mCN¥178.1m
Total liabilitiesCN¥140.7mCN¥262.4mCN¥359.7mCN¥343.4m
Debt—CN¥81.9mCN¥69.2mCN¥187.9m
Shareholders' equityCN¥320.1mCN¥115.6mCN¥131.4mCN¥116.1m
Shares outstanding59m49m59m59m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022
Cash from operationsCN¥94.0mCN¥100.6mCN¥149.0mCN¥119.9m
Capital spending−CN¥13.9m−CN¥158.4m−CN¥393.5m−CN¥278.8m
Free cash flowCN¥80.1m−CN¥57.8m−CN¥244.5m−CN¥158.9m
Dividends paid−CN¥19.4m−CN¥48.3m−CN¥46.2m−CN¥46.0m

Latest quarters

By quarter end

Jun 2025Jun 2024Sept 2014
RevenueCN¥185.8mCN¥204.5mCN¥20.0m
Gross profitCN¥70.3mCN¥74.8mCN¥9.0m
Operating incomeCN¥34.0mCN¥36.8mCN¥244,408
Net incomeCN¥15.9mCN¥20.4mCN¥122,140
Diluted earnings per share0.270.410.01
Cash from operationsCN¥35.0mCN¥45.0m—
Capital spending−CN¥8.0m−CN¥144.0m−CN¥2.0m
Free cash flowCN¥27.0m−CN¥99.0m—
Total assetsCN¥350.6m—CN¥33.5m
Cash and short-term investmentsCN¥79.8m—CN¥1.4m
DebtCN¥65.4m——
Shareholders' equityCN¥132.4m—CN¥18.5m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-3.2%——
Operating income0.3%——
Net income-8.8%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin51.5%51.6%——

Valuation history

At each fiscal year end

FY2025
Price to earnings15.9
Price to sales1.2

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.